Nyxoah to Participate in Upcoming Investor Conferences
Mont–Saint–Guibert, Belgium "" September [...] Read more »
Nyxoah Participera à de Prochaines Conférences d'Investisseurs
Nyxoah Participera de Prochaines Confrences d'Investisseurs
Read more »
GMAC Expands Global Representation in Board and School Membership
RESTON, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) — The Graduate Management Admission Council (Read more »
GMAC erweitert globale Repräsentanz im Vorstand und bei den Mitgliedsschulen
RESTON, Virginia, Sept. 05, 2023 (GLOBE NEWSWIRE) — Der Graduate Management Admission Council (Read more »
Le GMAC étend sa représentation mondiale au sein de son conseil d'administration et accueille une nouvelle école
RESTON, Virginie, 05 sept. 2023 (GLOBE NEWSWIRE) — Le Graduate Management Admission Council (Read more »
eLichens is introducing the first Natural Gas Detector integrating NB-IoT/LTE-M Connectivity from Sequans
GRENOBLE, France, Sept. 05, 2023 (GLOBE NEWSWIRE) — eLichens, a leading provider of non–dispersive infrared sensors and detectors, is thrilled to announce the collaboration with Sequans, resulting in the latest [...] Read more »
Zenas BioPharma gibt strategische Lizenz- und Kooperationsvereinbarung mit Bristol Myers Squibb zur Entwicklung und Vermarktung des neuartigen bifunktionalen Antikörpers Obexelimab in Japan, Südkorea, Taiwan, Singapur, Hongkong und Australien bekannt
Die Zusammenarbeit frdert die Vision von Zenas, Patienten weltweit innovative immunologische Medikamente zur Verfgung zu stellen, indem das Unternehmen die langjhrige Expertise von Bristol Myers Squibb auf dem Gebiet der [...] Read more »
Zenas BioPharma Fecha Acordo de Licenciamento e Colaboração Estratégica com a Bristol Myers Squibb para Desenvolvimento e Comercialização do Novo Anticorpo Bifuncional Obexelimab no Japão, Coreia do Sul, Taiwan, Cingapura, Hong Kong e Austrália
Colaborao promove a viso da Zenas de oferecer medicamentos inovadores baseados em imunologia para pacientes em todo o mundo, aproveitando a experincia de longa data da Bristol Myers Squibb com doenas imunomediadas
Zenas BioPharma annonce un accord de licence et de collaboration stratégique avec Bristol Myers Squibb dans le but de développer et commercialiser le nouvel anticorps bifonctionnel obéxélimab au Japon, en Corée du Sud, à Taïwan, à Singapour, à Hong Kong et en Australie
Cette collaboration renforce la vision de Zenas consistant apporter des mdicaments innovants bass sur l'immunologie aux patients dans le monde entier en s'appuyant sur l'expertise de longue date de Bristol [...] Read more »
Zoom introduces Zoom AI Companion — available at no additional cost with paid Zoom user accounts
SAN JOSE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. (NASDAQ: ZM) announced that Read more »
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia
Collaboration furthers Zenas' vision to bring innovative immunology–based medicines to patients around the world by leveraging Bristol Myers Squibb's long–standing expertise in immune–mediated [...] Read more »
Lawmakers Call on G20 to Prioritise Spending on Youth, Gender, and Human Security
![Asian Parliamentarians believe it’s important to prioritise [...] <a class=](https://www.ipsnews.net/Library/2023/09/7E5A1099-コピー-300x200.jpg)
Read more »
Africa’s Potential: Leading Food System Transformation and Climate Resilience
By Angela Churie Kallhauge, Ishmael [...] Read more »
When the UN Came Under Attack— from a Mis-Guided Rocket Launcher
Ernesto "Che" Guevara, [...] Read more »
NDB Spotlight: The Lesotho Highlands Water Project – Who Benefits?
Farmer in Lesotho. Credit: [...] Read more »